Cheng Ean Chee

9PUBLICATIONS
74CO-AUTHORS
Molecular targetsCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 25, 2026
Biomarker analysis from patients with metastatic PDAC treated with TGFβ antibody, NIS793, plus abraxane+gemcitabine vs. abraxane+gemcitabine alone in a phase II, open label, randomized study.

|Aug 01, 2025
Charting New Paths in Cancer Research: Insights from the Frontiers in Cancer Science Conference 2024.

Giang Le Minh, Sasidharan Swarnalatha Lucky, Shazib Pervaiz

|May 20, 2024
State-of-the-Art Management of Colorectal Cancer: Treatment Advances and Innovation.

Priyadarshini S Pathak, Gloria Chan, Dustin A Deming

|Apr 15, 2023
A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies.

Cheng E Chee, Melissa Ooi, Soo-Chin Lee

|Feb 16, 2023
Clinical outcome and prognostic factors for Asian patients in Phase I clinical trials.

Jerold Loh, Jiaxuan Wu, Jenny Chieng

|Apr 01, 2022
Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor-Positive Breast Cancer.

Joline S J Lim, Andrea L A Wong, Samuel G W Ow

Pageof 2

Frequent Collaborators

3 joint publications

Raghav Sundar

2 joint publications

Lingzhi Wang

2 joint publications

Pinelopi Andrikakou

2 joint publications

Tim Meyer